A United States Food and Drug Administration (FDA) advisory panel has advocated the use of coronavirus vaccines in children between the ages of six months and five years. Both the vaccine from the manufacturers Biontech and Pfizer and the preparation from Moderna could be used for this, the committee decided unanimously on Wednesday after hours of discussion.
The outcome of the vote is not binding on the FDA, but the authority usually follows the advisors’ assessment. The CDC has yet to agree. This could soon start with coronavirus vaccinations in this age group in the US. A few days ago, the US government said it would be expected from June 21.
No vaccine for young children in EU yet
The Biontech/Pfizer vaccine is currently approved in the US for children ages five to 11 and the Moderna vaccine for people aged 18 and older. On Tuesday, however, the FDA advisory committee had already voted in favor of approving Moderna’s vaccine for children and adolescents between the ages of six and 17.
There is currently no corona vaccine approved for very young children in the EU. The European Medicines Agency EMA in Amsterdam is currently investigating whether the vaccine from the manufacturer Moderna (Spikevax) can also be approved for children under six years of age. Such a test has not yet started for the vaccine from the manufacturers Biontech and Pfizer. According to the EMA, the manufacturers have not yet submitted a corresponding application for renewal of the approval.
Source: Krone
I’m Wayne Wickman, a professional journalist and author for Today Times Live. My specialty is covering global news and current events, offering readers a unique perspective on the world’s most pressing issues. I’m passionate about storytelling and helping people stay informed on the goings-on of our planet.
